Orphapacket:
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Adolescent
  - AverageAgeOfOnset:
      value: Adult
  - AverageAgeOfOnset:
      value: Childhood
  - AverageAgeOfOnset:
      value: Elderly
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
    Reference: '608710'
    Source: OMIM
  Genes:
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: '142880'
        Source: OMIM
      - Reference: '4938'
        Source: HGNC
      Name: major histocompatibility complex, class II, DP alpha 1
      Symbol: HLA-DPA1
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: '4940'
        Source: HGNC
      - Reference: '142858'
        Source: OMIM
      - Reference: HLA-DPB1
        Source: ClinVar
      Name: major histocompatibility complex, class II, DP beta 1
      Symbol: HLA-DPB1
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: CTLA4
        Source: ClinVar
      - Reference: '2505'
        Source: HGNC
      - Reference: '123890'
        Source: OMIM
      Name: cytotoxic T-lymphocyte associated protein 4
      Symbol: CTLA4
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: '9652'
        Source: HGNC
      - Reference: '600716'
        Source: OMIM
      - Reference: PTPN22
        Source: ClinVar
      Name: protein tyrosine phosphatase non-receptor type 22
      Symbol: PTPN22
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: PRTN3
        Source: ClinVar
      - Reference: '9495'
        Source: HGNC
      - Reference: '177020'
        Source: OMIM
      Name: proteinase 3
      Symbol: PRTN3
  Label: Granulomatosis with polyangiitis
  ORPHAcode: '900'
  ORPHApacketId: '900'
  PURL: http://www.orpha.net/ORDO/Orphanet_900
  Parents:
  - Parent:
    - Label: Anti-neutrophil cytoplasmic antibody-associated vasculitis
      ORPHAcode: '156152'
  - Parent:
    - Label: Systemic vasculitis associated with glomerulopathy
      ORPHAcode: '567560'
  - Parent:
    - Label: Inflammatory and autoimmune disease with epilepsy
      ORPHAcode: '166484'
  - Parent:
    - Label: Systemic inflammatory disease associated with an acquired peripheral
        neuropathy
      ORPHAcode: '209007'
  - Parent:
    - Label: Disease associated with a genetic susceptibility or tested for a biomarker
      ORPHAcode: '231957'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000163
      HPOTerm: Abnormal oral cavity morphology
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000246
      HPOTerm: Sinusitis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000366
      HPOTerm: Abnormality of the nose
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000388
      HPOTerm: Otitis media
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000421
      HPOTerm: Epistaxis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000790
      HPOTerm: Hematuria
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001824
      HPOTerm: Weight loss
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001945
      HPOTerm: Fever
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002113
      HPOTerm: Pulmonary infiltrates
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002205
      HPOTerm: Recurrent respiratory infections
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002633
      HPOTerm: Vasculitis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002637
      HPOTerm: Cerebral ischemia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002829
      HPOTerm: Arthralgia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002955
      HPOTerm: Granulomatosis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002960
      HPOTerm: Autoimmunity
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0012378
      HPOTerm: Fatigue
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0100820
      HPOTerm: Glomerulopathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000093
      HPOTerm: Proteinuria
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000099
      HPOTerm: Glomerulonephritis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000579
      HPOTerm: Nasolacrimal duct obstruction
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000864
      HPOTerm: Abnormality of the hypothalamus-pituitary axis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000988
      HPOTerm: Skin rash
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001369
      HPOTerm: Arthritis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002017
      HPOTerm: Nausea and vomiting
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002027
      HPOTerm: Abdominal pain
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002093
      HPOTerm: Respiratory insufficiency
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002105
      HPOTerm: Hemoptysis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002206
      HPOTerm: Pulmonary fibrosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003565
      HPOTerm: Elevated erythrocyte sedimentation rate
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0005764
      HPOTerm: Polyarticular arthritis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0006510
      HPOTerm: Chronic pulmonary obstruction
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0006535
      HPOTerm: Recurrent intrapulmonary hemorrhage
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0009830
      HPOTerm: Peripheral neuropathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0011227
      HPOTerm: Elevated circulating C-reactive protein concentration
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012649
      HPOTerm: Increased inflammatory response
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012735
      HPOTerm: Cough
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0032230
      HPOTerm: Cytoplasmic antineutrophil antibody positivity
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0033557
      HPOTerm: Anti-proteinase 3 antibody positivity
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0033559
      HPOTerm: Anti-myeloperoxidase antibody positivity
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0034104
      HPOTerm: Anti-neutrophil elastase antibody positivity
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100532
      HPOTerm: Scleritis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100533
      HPOTerm: Inflammatory abnormality of the eye
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100539
      HPOTerm: Periorbital edema
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100749
      HPOTerm: Chest pain
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0200034
      HPOTerm: Papule
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000024
      HPOTerm: Prostatitis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000071
      HPOTerm: Ureteral stenosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000083
      HPOTerm: Renal insufficiency
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000126
      HPOTerm: Hydronephrosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000389
      HPOTerm: Chronic otitis media
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000407
      HPOTerm: Sensorineural hearing impairment
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000488
      HPOTerm: Retinopathy
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000491
      HPOTerm: Keratitis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000505
      HPOTerm: Visual impairment
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000520
      HPOTerm: Proptosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000763
      HPOTerm: Sensory neuropathy
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000822
      HPOTerm: Hypertension
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000873
      HPOTerm: Diabetes insipidus
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000979
      HPOTerm: Purpura
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001250
      HPOTerm: Seizure
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001287
      HPOTerm: Meningitis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001607
      HPOTerm: Subglottic stenosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001681
      HPOTerm: Angina pectoris
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001701
      HPOTerm: Pericarditis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001733
      HPOTerm: Pancreatitis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002091
      HPOTerm: Restrictive ventilatory defect
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002102
      HPOTerm: Pleuritis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002202
      HPOTerm: Pleural effusion
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002239
      HPOTerm: Gastrointestinal hemorrhage
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002301
      HPOTerm: Hemiplegia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002315
      HPOTerm: Headache
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0003326
      HPOTerm: Myalgia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0004936
      HPOTerm: Venous thrombosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0005214
      HPOTerm: Intestinal obstruction
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0006824
      HPOTerm: Cranial nerve paralysis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0011675
      HPOTerm: Arrhythmia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0025420
      HPOTerm: Diffuse alveolar hemorrhage
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0033608
      HPOTerm: Pulmonary nodule
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0100758
      HPOTerm: Gangrene
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0200042
      HPOTerm: Skin ulcer
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 16859601[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 16859601[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 10693883[PMID]_11156552[PMID]_22258386[PMID]_19790134[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 17553910[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 15696553[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 14872461[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 16960922[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 11156552[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 11083271[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 11760724[PMID]_11083271[PMID]_ ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 18771432[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: New Zealand
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 16368729[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 18799060[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 8546743[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 26989646[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 15647446[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 19604432[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 24932888[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 23838025[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 21798892[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 24560699[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 17699321[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 24932888[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 17582741[PMID]_25805746[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 28881446[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: GPA
  - Synonym: Wegener granulomatosis
  TextSection:
    Contents: A rare anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis
      characterized by necrotizing inflammation of small and medium vessels (capillaries
      venules and arterioles) resulting in tissue ischemia.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Not applicable
  copyright: Orphanet (c) 2025
  creationDate: '2025-12-09 10:41:42'
  version: 1.3.42 / 4.1.8 [2025-03-03]
